Navigation Links
Bioniche Pharma Launches Ibutilide Fumarate Injection
Date:1/12/2010

LAKE FOREST, Ill., Jan. 12 /PRNewswire/ -- Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals announced today the launch of Ibutilide Fumarate Injection, the generic equivalent of Corvert® from Pfizer Inc.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080702/AQW070LOGO)

"The addition of Ibutilide Fumarate Injection further demonstrates Bioniche Pharma's continued growth and dedication to a consistently expanding portfolio of injectables," said George Zorich, President, US Operations for Bioniche Pharma.

Bioniche Pharma will supply Ibutilide Fumarate Injection in 0.1 mg/mL, 10mL vials.

This product has a boxed warning relating to proarrhythmic effects including potentially fatal arrhythmias (e.g., polymorphic ventricular tachycardia) and consideration for use in patients with chronic atrial fibrillation. Please refer to the Bioniche Pharma website at www.bionichepharma.com for the complete prescribing information for this product, including the boxed warning.

About Bioniche Pharma:

Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets. The company's growth is fueled by an internal development pipeline and an aggressive acquisition strategy for products. Bioniche Pharma was acquired in February 2006 by RoundTable Healthcare Partners, a private equity firm based in
'/>"/>

SOURCE Bioniche Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
2. Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
3. Bioniche Pharma and Academic Pharmaceuticals, Inc. Announce the Introduction of Sotalol Hydrochloride Injection
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 21, 2014 Clementia ... Medicines Agency (EMA) has granted Orphan Medicinal ... product candidate, for the treatment of fibrodysplasia ... severely disabling genetic disease characterized by painful, ... and new abnormal bone formation. This process, ...
(Date:11/21/2014)... , Nov. 20, 2014  Market research firm Kalorama ... "Year of The Buy, in the medical device industry.  ... medical devices will produce just 3% growth this year, ... including acquisitions of product lines and entrance by acquisition ... survey of medical devices, The Global Market for ...
(Date:11/21/2014)... Nov. 20, 2014 /CNW Telbec/ - KLOX Technologies Inc. ... following appointments: Todd Martensen ... newly created role of Chief Commercial Officer, to oversee ... topical photoconverter gel for the treatment of chronic and ... wounds, recently approved in Europe . ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4
... YORK, March 7, 2011 Reportlinker.com announces that a ... Neuroprotection - Drugs, Markets and Companies ... SummaryThis report describes the role of neuroprotection in ... nervous system as well as in chronic diseases such ...
... Ariz., March 7, 2011 Xeridiem Medical Devices strengthened ... Vice President, Business Development. Joseph Lee, Xeridiem ... that Renae Moomjian has joined Xeridiem Medical Devices as ... have primary responsibility to grow Xeridiem,s design and development ...
Cached Medicine Technology:Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 2Xeridiem Medical Devices Appoints Renae Moomjian, Vice President, Business Development 2
(Date:11/21/2014)... TX (PRWEB) November 21, 2014 ... Benefit Solutions , will present advanced benefits administration ... 6th Annual Houston HR Leadership Summit. This Game ... Human Resources industry to present cutting-edge solutions and ... presentation will explain how real-time data exchange between ...
(Date:11/21/2014)... Orange County, CA (PRWEB) November 21, 2014 ... be featured in an upcoming episode of Innovations with ... 2015. Dates and show times TBA. , Big Bud ... with information for growing, harvesting, and utilization of medical ... look at Big Bud Farms’ wide variety of products ...
(Date:11/21/2014)... In summer, when it’s hot out, people ... and rarely feel thirsty. As a result, less urgency ... of fresh water a day recommended for health and ... Kleyne. Winter weather is often more dehydrating than summer ... , The syndicated Sharon Kleyne Hour™ ...
(Date:11/21/2014)... Recently, TideStore.com, a leading online store offering ... special offer TideStore Thanksgiving Sales . According to ... now provided with big discounts. The special offer is ... an extra 10% discount with this coupon code: thanks. ... have opportunities to win free gifts. TideStore.com has done ...
(Date:11/21/2014)... West Palm Beach, FL (PRWEB) November 21, 2014 ... Administration report issued on June 11th, 2014, ... Takata Corporation can rupture when the airbag inflates. The ... break into metal shrapnel, and the metal shards may ... anyone within the vehicle’s cabin. , According to ...
Breaking Medicine News(10 mins):Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 2Health News:Our Bodies Need Eight Glasses of Water a Day Even in Winter Reports Fresh Water Advocate 3Health News:Thanksgiving Sales from TideStore.com 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3
... say, , , MONDAY, Jan. 19 (HealthDay News) -- Although ... risk for heart disease, knowing about it does not ... disease any more than using traditional risk factors, a ... in recent years about the power of gene variations ...
... diagnosed with early-stage lung cancer are not seen when ... in the January issue of Archives of Surgery ... causes more deaths in the United States than any ... Pulmonary resectionor surgery to remove a portion of the ...
... better, regardless of race, study found , , MONDAY, Jan. ... black patients with early-stage lung cancer disappear when black ... that included nearly 18,000 patients. , Surgery to ... the best chance of a cure for patients with ...
... of blood pressure, other factors may be boosting survival, ... First-time heart attacks in the United States aren,t as ... a long-running study finds. , "We know that deaths ... Meyerson, director of the cardiovascular disease prevention program at ...
... in healthcare services at Affiliated Computer Services, Inc. (NYSE: ... ranking in a national survey for the second consecutive ... award for its work in the Financial Enterprise Resource ... 20 Best in KLAS Awards: Software & Professional Services ...
... Inc.,(Nasdaq: BLUD ), a global leader ... industry, announced today that Michael Pred,has joined the ... U.S. manufacturing operations. , ... manufacturing experience,with both Pfizer and Merck & Co. ...
Cached Medicine News:Health News:Genetic Data May Not Boost Heart Disease Predictions 2Health News:Study examines racial disparities in survival among patients diagnosed with lung cancer 2Health News:Optimal Treatment Boosts Blacks' Lung Cancer Survival 2Health News:U.S. Heart Attacks Becoming Less Severe 2Health News:U.S. Heart Attacks Becoming Less Severe 3Health News:ACS is 'Best in KLAS' for Healthcare Financial Implementation Services for Second Consecutive Year 2Health News:ACS is 'Best in KLAS' for Healthcare Financial Implementation Services for Second Consecutive Year 3
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
Inquire...
Inquire...
Medicine Products: